The document discusses the herbal drug industry in India. It notes that India has a long history of using herbal medicines and is considered the "Medicinal Garden of the World" with over 8,000 medicinal plants. The herbal drug industry in India is large and growing, with a current market size of Rs. 7,000 crore annually. However, India has not capitalized fully on international trade of herbal products. The global herbal market is also growing steadily and is projected to reach $86.74 billion by 2022. For the herbal industry in India to realize its full potential, standardization, quality control, and further research on herbal medicines is needed.

1. HRRBAL DRUG INDUSTRY

2. Introduction
• Recently there has been a shift in universal trend from synthetic
to herbal medicine, which we can say ‘Return to Nature’
• Medicinal plants have been known for millennia & highly
esteemed all over the world as a rich source of medicinal
agents
• In our country, there are so many plants available, therefore
India known as ‘Medicinal Garden of World’.
• In India, system of medicine like Ayurveda, Siddha, Unani,
homeopathy, Yoga & Naturopathy are being utilized.
• Reason for popularity of natural products is that belief that all
are safe, non –toxic, less side effect, easily affordable prices.
• In international market now a days, herbal drug industry is very
fast growing sector. India has not done well in this international
trade of herbal products in market.
• In India, 8000/medicinal plant. 25 are manufacture in large scale.

3. Scope of Herbal Drug Industry
Herbal Market:
• Fastest growing market & may attain to 14,500 crore by 2012 & exports
to 9000 crore with a CAGR (compound annual growth rate) of 20 % &
25% respectively, according to Associated Chambers of Commerce &
Industry of India(Assocham)
• The ‘Herbal Industry Biz’ has reviled that currently, the Indian herbal
market size is estimated at 7000 crore & over 3600 crore of herbal raw
materials & medicine are exported by india.
• Reason for unexpected growth of herbal farm by government for improving
quality of drugs and promotion of exports.
• Larger economic development.
• Plays important role for the development of new research .
• Annual turnover in India: Ayurveda-US $ 300 million,
Unani-Us $ 27.5 million

4. Points to be look over precisely before introducing herbs in
pharmaceuticals.
• Standardization of herbs
• Procurement from the correct source
• Identity of Common Adulterants by
microscopy or other techniques
• Quality of the herb
• Toxicity studies
• Herbal and Drug Interaction

5. World market
• The global herbal market has grown steadily in the last
few years.
• The market size is projected to reach USD 86.74 Billion
by 2022, at a CAGR of around 6.8% from 2016 to 2022.
• The growing awareness for preventive healthcare
methods is the major driving factor of this market.
Significance factors:
1. Preference of consumers for natural therapy
2. Concern regarding undesirable side effects of modern
disease.
3. Effective to many diseases.
4. Economic

6. • The global Herbal Medicine Market size was
valued at USD 84.5 billion in 2019 and is
anticipated to grow at a CAGR of 20.5% during
the forecast period.

7. Global industry
The market is dominated by players such as
• Archer Daniels Midland Company (U.S.),
• Glanbia plc (Ireland),
• Herbalife International of America, Inc. (U.S.),
• Blackmores (Australia),
• Nutraceutical International Corporation (U.S.).
• NBTY, Inc.(U.S.),
• Arizona Natural Products (U.S.),
• Ricola (Switzerland),
• NaturaLife Asia Co., Ltd. (Korea), and
• Bio-Botanica Inc. (U.S.).

8. Indian herbal scenario
• India’s domestic herbal industry is represented by 8610 licensed herbal
units.
• NMPB has extensively surveyed the herbal market of India in collaboration
with ICFRE, Dehradun.
• The estimate of consolidated commercial demand of herbal raw drugs for
the year 2014-15 has been has been estimated at 5,12,000 MT.
• Estimated Exports of Herbal Raw Drugs, including Extracts has been
estimated 1,34,500 MT in 2014-15.
• Estimated Consumption by Domestic Herbal Industry has been estimated
1,95,000 MT 2014-15.
• An Estimated 1,67,500 MT of Herbal Raw Drugs are also Used by Rural
Households every year.
• About 1178 medicinal plant species recorded in the practices of trade. Out
of which, 242 plant species are used in annual quantities of more than
100MT.
Source:https://nmpb.nic.in/content/marketing-trade
https://nmpb.nic.in/content/demand-and-supply-position-medicinal-plants

9. Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868382/
• India, about 80% of the rural population uses
medicinal herbs or indigenous systems of medicine.
• It is estimated that nearly 1100 plant species are used
by the Indian herbal industry, and the turnover of the
industry is more than Rs 80 billion.
• Herbal exports include medicines of AYUSH
(Ayurveda, Unani, Siddha, and homoeopathy)
products, which occupy a share of 3% of total Indian
pharmaceutical export. Seventy percent of export
from the herbal sector consists largely of raw
materials and is estimated to be Rs. 10 billion per
annum.

10. • Source: https://www.nistads.res.in/all-html/Indian%20Herbal%20Sector.html

11. Industry
• The recent surge in in use of herbal medicines has led to a
sudden increase in herbal manufacturing units.
• The turnover of AYUSH industry is estimated to be more than
Rs 8800 crore.
• The domestic market of Indian systems of medicine &
Homoeopathy (ISM&H) is of the order of Rs 4000 Crore with
a total consumption of all botanicals to a figure of 177000
MT, which is expanding day by day.
• The total annual turnover of the Ayurvedic drug manufacturing
industry is estimated to be around Rs.3,500 Crore.
• Besides this, there is also a growing demand for natural
products including items of medicinal value/pharmaceuticals,
food supplements and cosmetics in both domestic and
international markets.

12. Manufacturing units
• There is a complex of large number of manufacturing
units using herbal material for various purposes.
• There are total of 9,493 manufacturing units, of
which mostly are small scale units (8,000) having an
annual turnover of less than one Crore.
• Some of the well known industrial houses with
annual turnover of more than 50 Crores are Dabur,
Zandu, Himalaya, Shree Baidyanath, Arya Vaidya
Shala etc.
• Though the number of manufacturing units with
higher turnover is less, still they are the ones which
consume about 35 % of the total raw material used.

15. EXIM scenario (2005-06)
• The annual demand of botanical raw drugs in the
country was estimated at approx 320 MT for 2005-06.
• Around 70% of the Indian exports from
the AYUSH sector consist largely of raw materials
and are estimated to be of the order of Rs 1000 crore
per annum.
• The balance consists of finished products including
herbal extracts.

16. • Export: The total quantity of exported medicinal plants including plant
extracts was 57880 MT.
• Psyllium exports constituted 35.6 % of total exports of medicinal plants
followed by Senna (18.9%).
• The total value of plant raw drugs exported (excluding extracts) was Rs.
354.8 Crores corresponding to a quantity of 56,500 MT.
• The annual export of India’s herbal sector added to Rs. 807 Crores as
per DGCIS-Directorate General of Commercial Intelligence and Statistics
data. This includes exports worth Rs. 354.80 Crores relating to plant raw
drugs, Rs.161 Crores relating to plant extracts and Rs. 291 Crores to
medicants of AUS and H.
• It shows that the finished herbal products constitute nearly 36 % of the
total exports of India’s herbal sector and the balance 64 % exports are in
the form of raw materials and extracts. On comparing the export data
with previous year (2007) shows a sizeable increase of Rs. 185 Crores
i.e. nearly 30 %.
• Import: Total 40 (number) commodities were enlisted for import. The
consolidated figures of such imports amounted to 37,483 MT (Rs.173
Crores) and Gum Arabic constituted the largest proportion by quantity
(12,731 MT; 34 %).

21. • Source: Manish et al., 2015

22. Research Approach to Herbal
Products
• Source:. Vaidya & Devasagayam et al., 2007

24. Future prospects of herbal medicine
• In the face of the increasing use and fast-growing market of herbal medicines and other
herbal healthcare products, in both developing and developed countries of the world,
policy-makers, health professionals and the public are increasingly expressing concerns
about the safety, efficacy, quality, availability, preservation, and further development
problems of these herbal products.
• Public demand has also grown for evidence on the safety, efficacy and quality of herbal
products and TM/CAM practices.
• Extensive research on herbal medicines is needed to be undertaken not only for their great
healthcare value but also for the commercial benefits. phytochemical and pharmacological
researches- efforts are being made to isolate and identify their active chemical constituents
and to substantiate the claims of their efficacy and safety.
• Important the concerns and demands of the policy makers, health professionals and even
public should encourage the use of herbal medicines.
• However, in order to ensure quality and safety of herbal medicines, their production, sale
and use should be officially and legally controlled, as done with allopathic medicines, by
established rules and regulations.
• Proper use of herbal medicinal products of 'assured quality' is sure to produce beneficial
therapeutic effects on the users and reduce the risks associated with them.
• Furthermore, use of adulterated herbal ingredients and inappropriate formulation must be stopped as
these may result in the production of low-quality and harmful or even dangerous herbal medicines.
Therefore, rules and regulations of GMP should be strictly followed in the production of herbal
medicines.
• With this cautionary note, it may be concluded safely that herbal medicines hold good future prospects
and they may, one day emerge as good substitutes or better alternatives for synthetic chemicals-based
allopathic drugs or may even replace them.